Home / PDA Letter / Full Article

PDA Comments: Viral Testing for Gene Therapies

by Rebecca Stauffer, PDA

Published On Apr 1, 2019

Last December, PDA submitted comments to the U.S. FDA regarding Replication Competent Retrovirus (RCR) testing for gene therapy products.

The contents of "PDA Comments: Viral Testing for Gene Therapies" are available to PDA members. Please sign up or log in to read the full article.